| Chairman |
|
Liu Heng |
| Business Nature |
| 醫療保健 (Health Care) |
| Board Members |
Chairman, Chief Executive Officer & General Manager: Liu Heng
Executive Director: Sun Nai Chau Bill, Xie Ming
Non-executive Director: Lin Jian, Gu Qin, Xue Di, Xue Kailu
Independent Non-executive Director: Siu Yu Hay Paul, Ruan Tim, Yang Chun, Zhou Guofang.
|
| Principle Business |
|
The Group is principally engaged in the research, development, manufacture and commercialisation of pharmaceutical products in the PRC. |
| Related Indexes | | Hang Seng Healthcare Index | Hang Seng Healthcare Industry Index | | Hang Seng Composite SmallCap Index | Hang Seng Composite Index |
|
| Major Shareholders |
| Liu Heng | 13,347,056 | H Sh | 17.99% | 18.30% | 2026/06/05 | | Sun Nai Chau Bill | 13,150,103 | H Sh | 17.72% | 18.03% | 2026/06/05 | | Mao Lifen & ASSO | 12,734,228 | H Sh | - | 16.96% | 2026/07/06 | | Shenzhen Oriental Fortune Capital Co., Ltd. | 4,248,937 | H Sh | 5.73% | 5.83% | 2026/06/05 |
|
|
|
|
|